The CYP2C19*2 and CYP2C19*3 polymorphisms are associated with high post-treatment platelet reactivity in Asian patients with acute coronary syndrome.
Kim
I-S
IS
Choi
B-R
BR
Jeong
Y-H
YH
Kwak
C H
CH
Kim
S
S
D054058:Acute Coronary Syndrome / Q000097:blood* / Q000201:enzymology; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics*; D044466:Asian People; D001792:Blood Platelets / Q000166:cytology*; D065731:Cytochrome P-450 CYP2C19; D006801:Humans; D007527:Isoenzymes / Q000235:genetics*; D010974:Platelet Aggregation; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic
D007527:Isoenzymes; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19